Status: affected by circulating vaccine-derived poliovirus type 1 and type 2 (VDPV2)
The Philippines is affected by both circulating vaccine-derived poliovirus type 1 (cVDPV1) and circulating vaccine-derived poliovirus type 2 (cVDPV2)
Polio this week in Philippines
- One case of circulating vaccine-derived poliovirus type 1 (cVDPV1) was reported this week from the West Mindanao province. The onset of paralysis was 28 October 2019. This is the first reported cases of cVDPV1 in 2019.
- Three cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) were reported this week from the Autonomous Region in Muslim Mindanao province. The onsets of paralysis were between 02 and 25 October 2019.
- Read our Philippines country page for more information.
It is important that all countries, in particular those with frequent travel and contacts with polio-affected countries and areas, strengthen surveillance for AFP cases in order to rapidly detect any new virus importation and to facilitate a rapid response. Countries, territories and areas should also maintain uniformly high routine immunization coverage at the district level to minimize the consequences of any new virus introduction.
International Health Regulations
Philippines is classified by the International Health Regulations (IHR) as a state infected with VDPV2, with potential risk of international spread. It is therefore subject to temporary recommendations as of September 2019.
WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.